Ambrisentan

Type: Keyphrase
Name: Ambrisentan
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Gilead beats forecasts as Sovaldi sales soar

US anti-virals specialist biotech firm Gilead Sciences (Nasdaq: GILD) has reported surging second-quarter 2014 sales and profits, boosted by a sharp quarter on quarter rise in revenues from its latest hepatitis C drug Sovaldi (sofosbuvir) and exceed analysts’ ... [Published Pharma Letter - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Macitentan, A New Tool in Pulmonary Arterial Hypertension

Atsmon, J., Dingemanse, J., Shaikevich, D., Volokhov, I. and Sidharta, P. (2013) Investigation of the effects of ketoconazole on the pharmacokinetics of macitentan, a novel dual endothelin receptor antagonist, in healthy subjects. Clin Pharmacokinet 52: ... [Published General Medicine eJournal - Jul 23 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

CHEST guideline released for PAH

An updated CHEST guideline for treating pulmonary arterial hypertension (PAH) provides some evidence-based recommendations but also highlights many evidence gaps.The guideline authors – Joe Ornelas (American College of Chest Physicians, Glenview, Illinois, ... [Published News-Medical.Net - Jul 15 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Industry up in arms against NPPA for bringing 108 non-scheduled drugs under price control

The pharmaceutical industry in the country is up in arms against the recent notification of the National Pharmaceutical Pricing Authority (NPPA) in which the national drug price regulator has brought prices of 108 non-scheduled formulation packs involving ... [Published PharmaBiz - Jul 15 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

CHEST guideline released for PAH

medwireNews: An updated CHEST guideline for treating pulmonary arterial hypertension (PAH) provides some evidence-based recommendations but also highlights many evidence gaps.The guideline authors – Joe Ornelas (American College of Chest Physicians, Glenview, ... [Published MedWire News - Jul 11 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Orphan designation: Ambrisentan, for the: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Anti-Hypotensive Treatment and Endothelin Blockade Synergistically Antagonize Exercise Fatigue in Rats under Simulated High Altitude

by Daniel Radiloff, Yulin Zhao, Alina Boico, Gert Blueschke, Gregory Palmer, Andrew Fontanella, Mark Dewhirst, Claude A. Piantadosi, Robert Noveck, David Irwin, Karyn Hamilton, Bruce Klitzman, Thies SchroederRapid ascent to high altitude causes illness ... [Published Plosone.org - Jun 25 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

Ambrisentan Therapy in Pulmonary Hypertension

Badesch, D., Feldman, J., Keogh, A., Mathier, M., Oudiz, R., Shapiro, S. et al . (2012) Aries-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension. Cardiovasc Ther 30: 93–99.Ben-Yehuda, O., Pizzuti, D., Brown, A., Littman, ... [Published General Medicine eJournal - Jun 23 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Methods of treating mixed dyslipidemia

Description of the InventionBACKGROUNDCardiovascular disease is one of the leading causes of death in the United States and most European countries. It is estimated that over 70 million people in the United States alone suffer from a cardiovascular disease ... [Published PharmCast - Apr 08 2014]

More Content

All (10) | News (8) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Gilead beats forecasts as Sovaldi sales soar [Published Pharma Letter - Jul 24 2014]
Macitentan, A New Tool in Pulmonary Arterial Hy... [Published General Medicine eJournal - Jul 23 2014]
CHEST guideline released for PAH [Published News-Medical.Net - Jul 15 2014]
Industry up in arms against NPPA for bringing 1... [Published PharmaBiz - Jul 15 2014]
CHEST guideline released for PAH [Published MedWire News - Jul 11 2014]
Orphan designation: Ambrisentan, for the: Treat... [Published Orphan designations - Jul 10 2014]
Anti-Hypotensive Treatment and Endothelin Block... [Published Plosone.org - Jun 25 2014]
Ambrisentan Therapy in Pulmonary Hypertension [Published General Medicine eJournal - Jun 23 2014]
Methods of treating mixed dyslipidemia [Published PharmCast - Apr 08 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Orphan designation: Ambrisentan, for the: Treat... [Published Orphan designations - Jul 10 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.